Protein and blood in the urine, known respectively as proteinuria and hematuria, signal that something is disrupting the kidney’s ability to filter blood cleanly. In many cases the cause is temporary and harmless, but when both appear together, or when either one persists, the odds of a significant kidney or urinary tract problem rise sharply. Sorting out what is going on requires more than a single urine test, and the long-term outlook hinges heavily on the underlying cause and how quickly it is identified.
How the Kidney Filter Normally Keeps Protein and Blood Out of Urine
Each kidney contains roughly a million tiny filtering units. At the core of each unit is a tuft of capillaries surrounded by specialized cells called podocytes, which form a structure sometimes compared to a coffee filter. Podocytes wrap around the capillaries and connect to one another through thin bridges called slit diaphragms. Over the past couple of decades, researchers have discovered that mutations in several proteins within these podocytes and their diaphragms are the main drivers of proteinuria, shifting the field’s understanding away from an older model that blamed the basement membrane alone.1PubMed Central. Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure Under normal conditions, this barrier keeps large molecules like albumin and blood cells on the capillary side. When it is damaged or disrupted, red blood cells can squeeze through gaps and appear in the urine as irregularly shaped, dysmorphic cells, a hallmark of glomerular hematuria.2PubMed Central. Pathogenesis of glomerular haematuria – Section: Abstract
When Protein or Blood in Urine Is Harmless
Not every positive urine test means kidney disease. Proteinuria can crop up after hard exercise, during a fever, or simply from standing upright for long periods. These transient forms are common, especially in younger people, and they resolve on their own without any lasting kidney damage.3PubMed. A practical approach to proteinuria Exercise-related hematuria follows a similar pattern: blood can appear in the urine after intense physical activity, particularly long-distance running, and then clear within a day or two. Studies have confirmed that healthy athletes who develop exercise-induced proteinuria or hematuria are not at elevated risk for future kidney problems.4Clinics in Sports Medicine. Renal Complications of Exercise – Section: Abstract
The practical takeaway is that a single abnormal urine test, especially one collected right after vigorous activity or during an illness, does not warrant alarm. Doctors typically repeat the test on a calm day before pursuing further workup. Proteinuria that persists across multiple samples collected at rest, however, shifts from “probably nothing” to “needs investigation.”
Causes of Persistent Proteinuria
When proteinuria sticks around, the cause usually falls into one of two broad camps: glomerular or tubular. Glomerular proteinuria happens when the kidney filter lets albumin and other large proteins slip through. Conditions that do this range from minimal change disease, common in children, to focal segmental glomerulosclerosis (FSGS) and membranous nephropathy in adults. In FSGS and minimal change disease, how fast kidney function declines over a decade tracks closely with the absolute amount of protein being spilled.5PubMed Central. Long-Term Outcomes in Nephrotic Syndrome by Kidney Biopsy Diagnosis and Proteinuria – Section: Results Tubular proteinuria, on the other hand, involves smaller proteins that are normally reabsorbed in the kidney’s tubules. When those tubular cells are injured, the smaller proteins escape into the urine even though the glomerular filter itself is intact. Diabetic kidney disease, the single most common cause of significant proteinuria worldwide, often involves damage to both zones.
Heavy proteinuria, sometimes called nephrotic-range when it exceeds about 3.5 grams per day, can produce visible symptoms: foamy urine, swelling around the eyes and ankles, and elevated cholesterol. Lower-grade proteinuria can persist for years without any symptoms a person would notice, which is one reason routine screening matters in people with diabetes or high blood pressure.
Causes of Isolated Hematuria
Blood in the urine without significant protein loss is a different clinical puzzle. Microscopic hematuria, meaning red blood cells visible under a microscope but not to the naked eye, shows up in roughly one in twenty people during routine screening.6PubMed Central. The Investigation of Hematuria – Section: Results In younger patients the source is often glomerular, with IgA nephropathy and thin basement membrane nephropathy being two of the most frequent culprits. In older adults, especially those with risk factors like smoking, male sex, or advanced age, non-glomerular sources become more concerning because they can include bladder or kidney cancer. That distinction matters enormously for the diagnostic path: glomerular hematuria warrants nephrology follow-up, while non-glomerular hematuria in a higher-risk patient calls for imaging and a look inside the bladder with a cystoscope.6PubMed Central. The Investigation of Hematuria – Section: Results
When Both Appear Together
The combination of hematuria and proteinuria, particularly alongside rising blood pressure or declining kidney function, points strongly toward active glomerular inflammation. This pattern is often called nephritic syndrome, and its most common causes include post-infectious glomerulonephritis, IgA nephropathy, and lupus nephritis.7PubMed Central. Clinical presentation & management of glomerular diseases: hematuria, nephritic & nephrotic syndrome Finding hematuria, proteinuria, and a reduced filtration rate together in someone with no prior kidney diagnosis is widely viewed as a strong reason to pursue a kidney biopsy, because the combination signals intrinsic kidney disease that can often be treated differently depending on its exact type.8PubMed Central. Aetiology of acute/subacute nephritic syndrome: results from kidney biopsy registries in Japan and Europe – Section: Abstract
How Doctors Begin Sorting It Out
The first pass at detecting proteinuria or hematuria is usually a urine dipstick, a paper strip dipped into a sample that changes color in response to protein or blood. Dipsticks are cheap and fast, which is why they remain ubiquitous. But they have real limitations. For protein detection, dipstick sensitivity for clinically meaningful levels of albumin loss is only moderate. One large population-based study found sensitivity of just under 44% for detecting an albumin-to-creatinine ratio above 30 mg/g, with a high rate of false positives and false negatives that reclassified about one in ten people into incorrect risk categories compared with a quantitative albumin-to-creatinine ratio test.9PubMed Central. Comparison of urine dipstick and albumin:creatinine ratio for chronic kidney disease screening: A population-based study Incorporating the urine’s specific gravity alongside the dipstick reading improves accuracy meaningfully.10PubMed Central. Specific Gravity Improves Identification of Clinically Significant Quantitative Proteinuria from the Dipstick Urinalysis – Section: Results But for confirming proteinuria, the more reliable approach is measuring the protein-to-creatinine ratio or albumin-to-creatinine ratio on a spot urine sample, which corrects for how concentrated the urine happens to be.
For hematuria, the dipstick detects hemoglobin on the strip, meaning it will also turn positive for hemoglobin released from broken-down red blood cells (hemoglobinuria) or from damaged muscle (myoglobinuria), even when there are no intact red blood cells in the urine at all.11PubMed Central. Hemoglobinuria misidentified as hematuria: review of discolored urine and paroxysmal nocturnal hemoglobinuria – Section: Abstract This is why a positive dipstick for blood is always followed by looking at the urine under a microscope.
What the Microscope Reveals
Microscopic examination of urine sediment is one of the oldest diagnostic tools in medicine, with roots stretching back six thousand years, though the modern version dates to the nineteenth-century introduction of the compound microscope.12PubMed. The fascinating story of urine examination: From uroscopy to the era of microscopy and beyond Today, the key question when red blood cells appear is their shape. Glomerular hematuria produces dysmorphic red blood cells, cells that have been deformed as they squeeze through damaged filter pores. Non-glomerular hematuria, from sources like kidney stones, infections, or tumors, produces red blood cells that look round and intact. Experienced labs can distinguish dozens of subtypes of normal and abnormal red blood cell shapes.13Scientific Reports. Enhancing the Detection of Dysmorphic Red Blood Cells and Renal Tubular Epithelial Cells with a Modified Urinalysis Protocol – Section: Results
Using a threshold of at least 25% dysmorphic red blood cells in one large study, the finding was not very sensitive for glomerular disease (it caught only about one in five cases) but was extremely specific, meaning that when it was present, the odds of a glomerular source exceeded 94%.14Nephrology Dialysis Transplantation. Urinalysis for the diagnosis of glomerulonephritis: role of dysmorphic red blood cells – Section: RESULTS In other words, the test misses many cases of glomerular bleeding, but when it flags one, you can trust it.
When a Kidney Biopsy Becomes Necessary
A kidney biopsy, in which a needle extracts a tiny core of kidney tissue for examination under a microscope, remains the definitive way to diagnose many causes of proteinuria and hematuria. It guides treatment decisions, helps estimate prognosis, and can identify whether a disease is relapsing in patients who were previously treated.15PubMed Central. Indications and considerations for kidney biopsy: an overview of clinical considerations for the non-specialist – Section: Abstract The procedure is invasive and carries a small but real risk of bleeding, so it is not done for every case of abnormal urine. Typical triggers include unexplained nephrotic-range proteinuria, the nephritic combination described above, rapidly worsening kidney function with an unclear cause, or suspicion of a systemic disease like lupus or vasculitis affecting the kidneys.
Genetic Causes of Persistent Hematuria
Some people live with microscopic hematuria for years, and genetic testing eventually reveals a hereditary cause. Alport syndrome and thin basement membrane nephropathy are closely related conditions caused by mutations in genes that produce type IV collagen, the main structural protein in the glomerular basement membrane.16PubMed. Alport syndrome and thin basement membrane nephropathy The clinical range is broad. Some people carry a single copy of a mutated gene and experience only mild, non-progressive hematuria throughout their lives. Others, particularly males with X-linked Alport syndrome, develop progressive kidney disease that can eventually require dialysis, along with hearing loss and eye abnormalities.17PubMed Central. A founder COL4A3 pathogenic variant resulting in Alport syndrome and thin basement membrane disease: a case report series
For families dealing with Alport syndrome, genetic counseling is valuable. The same mutations that cause thin basement membrane nephropathy in a carrier can cause full-blown Alport syndrome in their children if both parents carry a relevant variant. Understanding who in a family carries a mutation helps guide monitoring, and early treatment with blood-pressure medications can slow progression in affected individuals.
Drug-Induced Proteinuria
Medications are an underappreciated cause of new proteinuria. A large analysis of adverse-event reports spanning twenty years identified twenty-one drugs with statistically significant associations, with the strongest signals coming from voclosporin and the cancer drug lenvatinib. As a class, anticancer agents, immunosuppressants, and antiviral drugs were the most frequent offenders. The timing varied widely: anti-inflammatory drugs triggered proteinuria fastest, with a median onset of about five days, while antivirals and digestive-system drugs sometimes took years.18PubMed Central. Drug-related proteinuria: a vigilance analysis based on the FAERS database – Section: Results This delay can make it hard to connect the dots clinically: a patient started on a new antiviral might not develop proteinuria until over a thousand days later, long after anyone stops thinking of the drug as “new.”
Proteinuria in Pregnancy
Pregnancy deserves its own mention because the kidneys undergo dramatic physiological changes. Blood flow through the kidneys increases substantially, and the threshold at which protein in the urine becomes considered abnormal is higher than outside of pregnancy. The traditional cutoff is more than 300 mg in a 24-hour collection or a protein-to-creatinine ratio of 0.3 or above, but that number is based more on long-standing convention than on solid outcome data.19PubMed. Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance
The reason proteinuria gets tested so frequently in pregnant patients is preeclampsia, a condition combining high blood pressure and organ damage that affects roughly 3% to 8% of pregnancies. For over a century, proteinuria was a required criterion for diagnosing preeclampsia. Current guidelines no longer require it, recognizing that some cases of preeclampsia present with other forms of organ involvement instead. Still, in practice, most diagnoses of preeclampsia are made because of proteinuria appearing alongside gestational hypertension. Notably, the urine dipstick, which is probably the most commonly used screening method in prenatal visits, performs poorly for this purpose. Spot protein-to-creatinine ratios are more reliable as a rule-out test.19PubMed. Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance
Treatment Approaches
Treating proteinuria and hematuria means treating whatever is causing them, but two classes of medication deserve specific mention because they reduce proteinuria directly, independent of the underlying diagnosis, and that reduction itself protects the kidneys.
ACE inhibitors and angiotensin receptor blockers (ARBs) have been the cornerstone for decades. They lower pressure inside the glomerular capillaries, which reduces the amount of protein forced through the filter. Across multiple trials in both diabetic and non-diabetic populations, these drugs cut proteinuria and slow progression of kidney disease. A 50% drop in proteinuria during the first six to twelve months of treatment has been associated with a 40% to 50% reduction in the risk of the disease getting worse over time.20Australian Prescriber. Management of proteinuria: blockade of the renin–angiotensin–aldosterone system – Section: Efficacy
More recently, SGLT-2 inhibitors, originally developed for diabetes, have shown striking kidney-protective effects even in people without diabetes. In randomized trials, these drugs reduced proteinuria and slowed kidney disease progression in patients with significant albumin loss. Among patients with nephrotic-range proteinuria who took empagliflozin, about three-quarters achieved a sustained 30% or greater drop in their albumin-to-creatinine ratio, compared with fewer than half on placebo.21PubMed Central. SGLT-2 inhibitors in nephrotic-range proteinuria: emerging clinical evidence This has made SGLT-2 inhibitors a major addition to the treatment toolkit, often used alongside ACE inhibitors or ARBs.
Why Hematuria Resolution Matters for the Long-Term Outlook
Proteinuria has long been recognized as a predictor of kidney disease progression, but the independent role of hematuria has only come into sharper focus in recent years. In IgA nephropathy, the most common glomerular disease worldwide, persistent hematuria is an independent risk factor for disease progression. In one cohort study, hematuria that continued during follow-up raised the risk of kidney function decline by about 46%, while patients whose hematuria resolved within six months of diagnosis had a substantially lower chance of the disease worsening.22PubMed. Persistent Hematuria and Kidney Disease Progression in IgA Nephropathy: A Cohort Study – Section: RESULTS
The interplay between the two findings is telling. In a separate study of IgA nephropathy patients, those who had high proteinuria (above 0.75 g/day) and persistent hematuria fared the worst. But among patients with the same high proteinuria, those whose hematuria cleared saw meaningfully better kidney survival. In patients who achieved hematuria remission, the rate of kidney function decline went from a steep average loss to virtually flat.23PubMed Central. Remission of Hematuria Improves Renal Survival in IgA Nephropathy Hematuria resolution, in other words, appears to carry prognostic information beyond what proteinuria alone tells you.
Outside of IgA nephropathy, general population data reinforces the point. A large retrospective study found that people with persistent microscopic hematuria, even without known kidney disease, had over five times the risk of developing chronic kidney disease compared with those who never had hematuria. Even people whose hematuria came and went still faced nearly double the risk.24PubMed. Risk of CKD Following Detection of Microscopic Hematuria: A Retrospective Cohort Study The association was stronger in men than women, reinforcing the idea that persistent microscopic hematuria deserves ongoing monitoring rather than being dismissed.
Red Urine That Isn’t Blood
Before assuming that dark or reddish urine means hematuria, it is worth knowing about the mimics. Hemoglobinuria, caused by red blood cells breaking apart inside the bloodstream and releasing their hemoglobin, will turn the urine red or brown and trigger a positive dipstick, but the microscope will show no intact red blood cells. Myoglobinuria, from severe muscle damage, does the same thing. Certain medications, beets, and food dyes can also discolor urine without involving any blood at all.11PubMed Central. Hemoglobinuria misidentified as hematuria: review of discolored urine and paroxysmal nocturnal hemoglobinuria – Section: Abstract In surgical patients, red urine after procedures involving heart-lung bypass machines may reflect hemolysis during the circuit rather than a problem in the urinary tract itself.25PubMed. Red-Colored Urine in the Cardiac Surgical Patient-Diagnosis, Causes, and Management The distinction is clinically important: hemoglobinuria points toward blood disorders or mechanical red cell destruction, myoglobinuria toward rhabdomyolysis, and true hematuria toward the kidneys or urinary tract. The microscope and a few targeted lab tests sort them out quickly.
Emerging Urine Biomarkers
Standard urine tests measure protein or blood after kidney damage has already reached a certain threshold. A growing body of research aims to catch kidney injury earlier, using biomarkers that rise in the urine hours to days before the traditional marker, serum creatinine, starts climbing. Among the most studied are NGAL (neutrophil gelatinase-associated lipocalin), KIM-1 (kidney injury molecule-1), and cystatin C.26PubMed Central. Biomarkers for the early detection of acute kidney injury – Section: Abstract In patients undergoing cardiac surgery, where acute kidney injury is a known risk, urinary NGAL measured six hours after the procedure performed well for detecting severe injury, while urinary cystatin C at the time of arrival to intensive care picked up milder forms.27PubMed Central. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury – Section: Abstract Other markers, including MMP-9 and NAG, have also demonstrated the ability to flag acute kidney injury before creatinine rises.28PubMed Central. Urinary biomarkers in the early diagnosis of acute kidney injury – Section: Abstract
These biomarkers have not yet displaced traditional urine testing in routine clinical practice, partly because standardizing cutoff values and assay platforms across hospitals is still a work in progress. But in specific high-risk settings, particularly cardiac surgery and intensive care, they are starting to influence clinical decisions and are likely to become a more prominent part of kidney diagnostics in the coming years.